Large Molecule Drug Substance CDMO - Procurement Intelligence
Home / Procurement Intelligence / Drug Development and Manufacturing / Large Molecule Drug Substance CDMO

Procurement Market Intelligence Report

Large Molecule Drug Substance CDMO – Procurement Best Practices & Sourcing Strategies

Large Molecule Drug Substance CDMO Market – Executive Summary, COVID Section, Market Overview, Market Monitoring Insights, Market Trends, Supplier Section, RFP/RFI Builder

1. Executive Summary
1.1. Executive Summary
1.2. Supply Market Outlook
1.3. Demand Market Outlook
1.4. ELINT’s Recommendations for an Ideal Category Strategy
1.5. Negotiation Leverage
1.6. Talking Points
2. COVID Section
2.1. Sourcing Location Watch
2.2. Supplier Watch
2.3. Industry Watch
3. Market Overview
3.1. Category Overview
3.2. Market Overview
4. Market Monitoring Insights
4.1. Drug Substance Manufacturing Location
4.2. Cost Analysis and Expected Savings
5. Market Trends
5.1. Key Market Trends
5.2. Preferred Business Models
5.3. Impact of COVID-19 on Biologic CMO Market
6. Supplier Section
6.1. Key Global Suppliers
6.2. Supplier Profile
6.3. Supplier SWOT
6.4. Porter’s Five Forces Analysis
7. RFP/RFI Builder
7.1. RFP Builder
7.2. Sustainability Initiative

Additional Information

Purchase Option

Multiple User License, Single User License

Shopping Basket